The FDA Approved A Self-Administered Nasal Spray For The Flu. Here’s How It Compares To The Traditional Flu Shot

Forbes October 6, 2024
Omer Awan

The U.S. FDA recently approved FluMist as a self or caregiver-administered nasal spray flu vaccine to prevent Influenza disease. The nasal spray prevents the flu from Influenza virus subtypes A and B in individuals between the ages of 2 and 49. FluMist can now be administered by a healthcare provider at a pharmacy, or even self-administered by adults at the comfort of their homes.

The new approval provides a novel level of flexibility and accessibility for flu vaccine administration, as many may experience barriers to getting to healthcare facilities to receive the shot. In addition, many children and adults have a fear of needles, and the nasal spray circumvents that barrier as it is sprayed into the nose.

So how...

Today's Sponsors

Today's Sponsor